Evidence map›Paper›PMID 39291976›Full record

ArticlemSystems2024

Semantic search using protein large language models detects class II microcins in bacterial genomes.

Anastasiya V Kulikova, Jennifer K Parker, Bryan W Davies, Claus O Wilke

Abstract read
In one paragraph

Article in mSystems, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Prevalence and activity of class II microcins inApplied and environmental microbiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Anastasiya V KulikovaDepartment of Integrative Biology, The University of Texas at Austin, Austin, Texas, USA.ORCID 0000-0002-7964-7178
Jennifer K ParkerDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, USA.ORCID 0000-0002-4382-0741
Bryan W DaviesDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, Texas, USA.ORCID 0000-0002-2046-0341
Claus O WilkeDepartment of Integrative Biology, The University of Texas at Austin, Austin, Texas, USA.ORCID 0000-0002-7470-9261

Funding

Investigating nanobodies to target multidrug resistant bacterial pathogensR01AI148419 · NIAID · UNIVERSITY OF TEXAS AT AUSTIN · PI DAVIES, BRYAN WILLIAM · 2020 to 2023
$2.8M
Vibrio microcins. A hidden field of targeted anti-cholerae natural products.R01AI182365 · NIAID · UNIVERSITY OF TEXAS AT AUSTIN · PI Bryan William Davies · 2024 to 2026
$2.2M
Investigation of capsule interactions that promote antimicrobial peptide activityR21AI159203 · NIAID · UNIVERSITY OF TEXAS AT AUSTIN · PI DAVIES, BRYAN WILLIAM · 2021 to 2022
$429k
HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI148419HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI159203HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI182365NIAID NIH HHS R01 AI148419NIAID NIH HHS R01 AI182365NIAID NIH HHS R21 AI159203
6 · The paper itself

Abstract

Class II microcins are antimicrobial peptides that have shown some potential as novel antibiotics. However, to date, only 10 class II microcins have been described, and the discovery of novel microcins has been hampered by their short length and high sequence divergence. Here, we ask if we can use numerical embeddings generated by protein large language models to detect microcins in bacterial genome assemblies and whether this method can outperform sequence-based methods such as BLAST. We find that embeddings detect known class II microcins much more reliably than does BLAST and that any two microcins tend to have a small distance in embedding space even though they typically are highly diverged at the sequence level. In data sets of IMPORTANCE: Antibiotic resistance is becoming an increasingly serious problem in modern medicine, but the development pipeline for conventional antibiotics is not promising. Therefore, alternative approaches to combat bacterial infections are urgently needed. One such approach may be to employ naturally occurring antibacterial peptides produced by bacteria to kill competing bacteria. A promising class of such peptides are class II microcins. However, only a small number of class II microcins have been discovered to date, and the discovery of further such microcins has been hampered by their high sequence divergence and short length, which can cause sequence-based search methods to fail. Here, we demonstrate that a more robust method for microcin discovery can be built on the basis of a protein large language model, and we use this method to identify several putative novel class II microcins.

Indexed as

BacteriocinsGenome, BacterialAnti-Bacterial AgentsEnterobacterEscherichia coliKlebsiellaSemanticsAnti-Bacterial AgentsBacteriocinsmicrocinclass II microcinembeddingprotein large language model

Identifiers

PMID39291976
PMCPMC11494933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.